Displaying archives for 2014 October:

Therapy treats lung cancer based on patients’ genetic markers

Posted by Gianna Nannini on October 28th, 2014 |

SF Gate – October 28, 2014 – A new type of clinical trial for lung cancer patients getting under way at hospitals in the Bay Area and around the country may change the way drugs are tested in the future. That’s a pretty bold expectation, but researchers say the study — called the Lung Cancer… Read More

Smoke Free Doesn’t Mean Lung Cancer Free

Posted by Gianna Nannini on October 27th, 2014 |

HERS Magazine – November/December 2014 – Carol, a tall, slender married mom of four maintained an active lifestyle, walking at least two miles a day. When she began experiencing a persistent cough, pain in her legs, and feeling very sluggish, she scheduled a doctor’s visit. Her doctor prescribed medication for her nagging cough, but it… Read More

Lung cancer can stay hidden for 20 years before detection, study says

Posted by Samantha Powell on October 10th, 2014 |

Researchers in the United Kingdom have found that lung cancer can remain hidden up to 20 years before it is detectable, suggesting evidence for why the disease is the deadliest form of cancer worldwide. “The problem with lung cancer is we often diagnose patients too late,” said study author Charles Swanton, a professor of cancer… Read More

New research outlines promising therapies for small cell lung cancer

Posted by Samantha Powell on October 7th, 2014 |

Two recently published studies by a research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and “is a disease in urgent need of new drug… Read More

Myths About Cancer Care In America

Posted by Samantha Powell on October 6th, 2014 |

In an article titled “Five Myths about Cancer Care in America” coming out in the policy journal Health Affairs today, Dana Goldman* and I take on five common misperceptions in the policy community about cancer care in the US today. Below I discuss some of the evidence and arguments contained in that piece. Much has… Read More

Atlanta filmmaker documents cancer battle

Posted by Samantha Powell on October 6th, 2014 |

Part of our journey is finding that person — the one who will wait with you, the one who will navigate a world in which vows pledged in happiness are tested in ways never imagined. In this part of his life, Jonathan Hicks wears the title of patient, his path directed by doctors and drugs…. Read More

Advancing the development of new “targeted drug therapies” by enhancing the science of biomarkers

Posted by Samantha Powell on October 3rd, 2014 |

A key area of new drug development lies in the field of targeted therapies, sometimes called “personalized medicines,” which are drugs tailored to the genetic makeup of individual patients. These drugs are called targeted therapy because health care professionals can use clinical test results from a patient to select a specific drug that has a… Read More

The link between fat and cancer

Posted by Samantha Powell on October 2nd, 2014 |

You likely know that being overweight increases your risk for cardiovascular disease and diabetes. But did you know it also increases your risk for cancer? If you didn’t, you’re not alone. While around 90% of Americans know that smoking is linked to higher rates of cancer, Dr. Clifford Hudis says, the inverse is true for… Read More

Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab

Posted by Samantha Powell on October 2nd, 2014 |

Bristol-Myers Squibb recently announced key developments regarding its immuno-oncology drug nivolumab. The FDA in the U.S. has granted breakthrough status to the drug for advanced melanoma and has agreed to review the license application on priority basis. The review is likely to be completed by the end of March 2015. Additionally, the EMA (European Medicines… Read More

Roswell Park begins genomic testing for lung cancer

Posted by Samantha Powell on October 2nd, 2014 |

Targeted lung cancer testing has begun at Roswell Park Cancer Institute following approvals in late July from the state Department of Health. The hospital began clinical testing last month at its Center for Personalized Medicine, 18 months after announcing the launch of the facility. Though researchers began their work at the site in February of… Read More